Financings Roundup
Symphogen Financing Largest for Private European Biotech
Symphogen A/S, of Copenhagen, Denmark, has raised what it said is the largest financing ever for a private European biotech company with a $131 million preferred stock placement.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.